My name is Evaldo Favi, I have a PhD degree in Solid Organ Transplantation, and I work as an Associate Professor of Surgery at the Università degli Studi di Milano, Italy. Also, I work as a consultant Transplant and Vascular Access Surgeon at the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy. Being grateful to those who dedicated time and efforts to my education, I have understood how important it can be to have constructive exchange and how teaching should represent a major activity in both clinical and academic settings. As a surgeon, scientist, lecturer, and author, I am committed to providing the best learning experience to medical students, residents, colleagues, and readers. In line with this vision, I regularly attend national and international courses or conferences, and I have written several narrative and/or systematic reviews focusing on challenging or debated topics in transplantation. Importantly, I consider scientific research a key element in my professional life. My main areas of expertise and investigation are clinical immunosuppression, allograft rejection, recurrent primary renal diseases, post-transplant infectious (in particular, Polyomaviruses and Cytomegalovirus), cardiovascular, and neoplastic complications. Among the others, my research group has recently demonstrated in vivo the feasibility of a multimodality induction and treatment scheme combining the type-2 anti-CD20 compound obinutuzumab with anti-C5 monoclonal antibodies for the prevention and treatment of antibody-mediated rejection. Also, we have better defined risk factors, route of transmission, replication patterns, and clinical impact of human Polyomaviruses infection in kidney transplant recipients. I followed my studies graduating with top marks (Università Cattolica del Sacro Cuore, Italy). During my residency in General Surgery (Policlinico Universitario Fondazione Agostino Gemelli, Italy), I developed a special interest into transplantation. After obtaining a PhD in Solid Organ Transplantation, I moved to the UK. Working in top-level hospitals (Guy's and St Thomas', Great Ormond Street Hospital, and The Royal London Hospital), I was involved in national and international research projects, consolidating a deep interest in clinical research. According to Scopus, WOS, and/or Google Scholar, my academic contributions include 80 full-text articles (first, last, and/or corresponding author >50%) published in important academic journals, with 1265 total citations, a H-index of 20, 50% of articles originating from international collaborations, and 21% of documents in the top 25% most cited documents worldwide. During my career, I had 53 speeches at national or international academic conferences, winning a prize for the best abstract presented by a young author at the World Congress of Nephrology. My past and current professional associations’ memberships include Italian Society for Organ Transplantation, European Society for Organ Transplantation, General Medical Council and Specialty Register, and British Medical Association. I served as a reviewer for important academic journals (64 reviews registered in WOS) including JAMA Network, American Journal of Transplantation, Artificial Organs, Pediatric Transplantation, Renal Failure, and BMC Nephrology. As a senior Editorial Board Member, I lead the Kidney Transplantation Section of BMC Nephrology. Also, I am in the Transplantation Topical Advisory Panel for Medicina. As a Guest Editor, I led a number of special issues including: "Kidney Transplantation—Clinical and Surgical Challenges", Medicina; "Infectious Complications in Chronic Kidney Disease and Renal Transplant Patients: Prevention, Diagnosis, Management, and Emerging Trends", Pathogens; "Kidney Transplantation—Clinical and Surgical Challenges II", Medicina; "Health Economics Section", Frontiers in Public Health; "Assessing the Value and Cost of Organ Donation and Transplantation", Frontiers in Public Health. I have written at least 3 editorials for Frontiers in Public Health, Medicina, and Journal of Transplantation Technologies & Research, as well as several reviews or perspective articles for American Journal of Transplantation, World Journal of Transplantation, Hepatobiliary & Pancreatic Diseases International, Frontiers in Public Health, Medicina, Journal of Personalized Medicine, and International Journal of Molecular Sciences. My personal and professional goals include: the implementation of our institutional pediatric donation after circulatory death kidney transplant program, the creation of a national registry collecting data from all cases of kidney allograft neoplasms diagnosed and treated in Italy, the design and funding of a multicenter randomized clinical trial investigating a multimodality induction scheme with type-2 anti-CD20 and anti-C5 monoclonal antibodies for the prevention of antibody-mediated rejection in highly-sensitized deceased donor kidney transplant recipients, the design and funding of a multicenter randomized clinical trial assessing type-2 anti-CD20 and anti-C5 monoclonal antibodies for the treatment of antibody-mediated rejection in kidney transplant recipients, the development and validation of easy-to-use cardiovascular risk stratification tools for kidney transplant candidates and kidney transplant recipients, evaluating possible pharmacological strategies for the prevention or minimization of ischemia-reperfusion injury, gain further experience in international editorial settings, broadly expand my connections and research network in order to favor future collaborations and improve my academic potential. As a consultant transplant surgeon, my most distinctive technical or clinical achievements and areas of expertise are complex adult and pediatric living or deceased donor kidney transplants, adult and pediatric dialysis access procedures, and management of immunosuppression for ABO incompatible and HLA incompatible kidney transplant recipients. In this context, I certainly value my well-developed leadership, management, and problem-solving skills. As a scientist and academic professional, my most relevant trait is the ability to apply basic science principles to clinically driven research projects, investigating the rationale and feasibility of unexplored treatment options for major transplant-related complications. Being constantly involved in teaching, peer reviews, or editorial board activities, I do my best to promote and improve my listening, communication, interpersonal, and mentoring skills, aiming to favor a nurturing experience and environment for junior and senior colleagues. My favorite hobbies and interests are listening to audiophile music, watching classic movies, reading short novels, fine dining, fitness and exercise training.